JP2005512995A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005512995A5 JP2005512995A5 JP2003541815A JP2003541815A JP2005512995A5 JP 2005512995 A5 JP2005512995 A5 JP 2005512995A5 JP 2003541815 A JP2003541815 A JP 2003541815A JP 2003541815 A JP2003541815 A JP 2003541815A JP 2005512995 A5 JP2005512995 A5 JP 2005512995A5
- Authority
- JP
- Japan
- Prior art keywords
- tolterodine
- formulation according
- pharmaceutical
- pharmaceutical formulation
- antimuscarinic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 239000003149 muscarinic antagonist Substances 0.000 claims 5
- OOGJQPCLVADCPB-HXUWFJFHSA-N tolterodine Chemical group C1([C@@H](CCN(C(C)C)C(C)C)C=2C(=CC=C(C)C=2)O)=CC=CC=C1 OOGJQPCLVADCPB-HXUWFJFHSA-N 0.000 claims 5
- 229960004045 tolterodine Drugs 0.000 claims 5
- BDIAUFOIMFAIPU-UHFFFAOYSA-N valepotriate Natural products CC(C)CC(=O)OC1C=C(C(=COC2OC(=O)CC(C)C)COC(C)=O)C2C11CO1 BDIAUFOIMFAIPU-UHFFFAOYSA-N 0.000 claims 5
- 239000000556 agonist Substances 0.000 claims 4
- 229940011871 estrogen Drugs 0.000 claims 4
- 239000000262 estrogen Substances 0.000 claims 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 206010020853 Hypertonic bladder Diseases 0.000 claims 2
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 208000020629 overactive bladder Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34450701P | 2001-11-09 | 2001-11-09 | |
| PCT/SE2002/002041 WO2003039524A1 (en) | 2001-11-09 | 2002-11-07 | Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005512995A JP2005512995A (ja) | 2005-05-12 |
| JP2005512995A5 true JP2005512995A5 (https=) | 2005-12-22 |
Family
ID=23350815
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541815A Withdrawn JP2005512995A (ja) | 2001-11-09 | 2002-11-07 | 不安定又は過活動膀胱を治療するための抗ムスカリン剤及びエストロゲンアゴニスト |
| JP2003541844A Pending JP2005514345A (ja) | 2001-11-09 | 2002-11-12 | 更年期以降の女性生殖機能障害の治療のための組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541844A Pending JP2005514345A (ja) | 2001-11-09 | 2002-11-12 | 更年期以降の女性生殖機能障害の治療のための組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20030118633A1 (https=) |
| EP (2) | EP1441707A1 (https=) |
| JP (2) | JP2005512995A (https=) |
| CA (2) | CA2466336A1 (https=) |
| MX (2) | MXPA04003866A (https=) |
| WO (2) | WO2003039524A1 (https=) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005513080A (ja) | 2001-12-20 | 2005-05-12 | フェムファーマ， インコーポレイテッド | 薬物の膣送達 |
| AU2003287248A1 (en) * | 2002-11-12 | 2004-06-03 | Pharmacia And Upjohn Company | Combination therapy for postmenopausal female sexual dysfunction comprising an androgen, an estrogen and an antimuscarinic |
| US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| JP2006515026A (ja) | 2003-01-02 | 2006-05-18 | フェムファーマ ホールディング カンパニー， インコーポレイテッド | 乳房の疾患および障害の処置のための薬学的調製物 |
| US20040248989A1 (en) * | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
| US20060040904A1 (en) * | 2004-08-17 | 2006-02-23 | Ahmed Salah U | Vaginal cream compositions, kits thereof and methods of using thereof |
| JP5173190B2 (ja) * | 2004-08-25 | 2013-03-27 | 武田薬品工業株式会社 | 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法 |
| WO2006127057A1 (en) * | 2005-05-24 | 2006-11-30 | Lyle Corporate Drvelopment, Inc. | Non-systematic vaginal administration of estrogen and an androgen for the treatment of sexual dysfunction |
| WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
| WO2007011707A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
| WO2007076144A2 (en) * | 2005-12-27 | 2007-07-05 | Duramed Pharmaceuticals, Inc. | Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| ES2540059T3 (es) | 2006-04-26 | 2015-07-08 | Micell Technologies, Inc. | Recubrimientos que contienen múltiples fármacos |
| MX2008014825A (es) | 2006-05-22 | 2008-12-01 | Hormos Medical Ltd | Moduladores selectivos del receptor de estrogeno o inhibidores de aromatasa para tratar prostatitis cronica no bacteriana. |
| BRPI0711525A2 (pt) | 2006-06-02 | 2011-11-01 | Pear Tree Women S Health Care | composição farmacêutica e método para tratar sintomas de vaginite atrófica |
| CA2667228C (en) | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
| US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
| CA2679712C (en) | 2007-01-08 | 2016-11-15 | Micell Technologies, Inc. | Stents having biodegradable layers |
| US20080181932A1 (en) * | 2007-01-30 | 2008-07-31 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| AU2008256684B2 (en) | 2007-05-25 | 2012-06-14 | Micell Technologies, Inc. | Polymer films for medical device coating |
| EP2175843B1 (en) | 2007-08-08 | 2014-10-08 | Inventia Healthcare Private Limited | Extended release compositions comprising tolterodine |
| JP2011518783A (ja) * | 2008-04-09 | 2011-06-30 | コンサート ファーマシューティカルズ インコーポレイテッド | ３−（２−ヒドロキシ−５−メチルフェニル）−ｎ，ｎ−ジイソプロピル−３−フェニルプロピルアミンの誘導体およびその使用方法 |
| CN102083397B (zh) | 2008-04-17 | 2013-12-25 | 米歇尔技术公司 | 具有生物可吸收层的支架 |
| GR1006406B (el) * | 2008-05-06 | 2009-05-26 | Specifar Abee ���������� ������� ��� ������������� ��������� | Μικροδισκια παρατεταμενης αποδεσμευσης της τρυγικης τολτεροδινης |
| JP2011528275A (ja) | 2008-07-17 | 2011-11-17 | ミセル テクノロジーズ，インク． | 薬物送達医療デバイス |
| US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
| CA2756386C (en) | 2009-03-23 | 2019-01-15 | Micell Technologies, Inc. | Drug delivery medical device |
| WO2010120552A2 (en) | 2009-04-01 | 2010-10-21 | Micell Technologies, Inc. | Coated stents |
| EP3366326A1 (en) | 2009-04-17 | 2018-08-29 | Micell Technologies, Inc. | Stents having controlled elution |
| US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
| EP2453834A4 (en) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | MEDICAL DEVICE DISPENSING MEDICINE |
| EP2531140B1 (en) | 2010-02-02 | 2017-11-01 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
| US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
| EP2560576B1 (en) | 2010-04-22 | 2018-07-18 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
| WO2012009684A2 (en) | 2010-07-16 | 2012-01-19 | Micell Technologies, Inc. | Drug delivery medical device |
| WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
| CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
| US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
| EP2687215B1 (en) * | 2012-07-18 | 2018-11-28 | Georges Debled | Mesterolone pharmaceutical composition for dihydrotestosterone deficiencies in woman |
| US20140045806A1 (en) * | 2012-07-25 | 2014-02-13 | Fernand Labrie | Sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy |
| KR20150143476A (ko) | 2013-03-12 | 2015-12-23 | 미셀 테크놀로지즈, 인코포레이티드 | 생흡수성 생체의학적 임플란트 |
| HK1222313A1 (zh) | 2013-05-15 | 2017-06-30 | Micell Technologies, Inc. | 可生物吸收的生物医学植入物 |
| AU2014349132A1 (en) * | 2013-10-22 | 2016-04-14 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositons and methods |
| WO2018093369A1 (en) * | 2016-11-17 | 2018-05-24 | Goren Ofer A | Treatment of sexual dysfunction and for improved sexual quality of life |
| EP4398875A4 (en) * | 2021-09-10 | 2025-06-18 | Statera Pharma Inc. | Local delivery of growth and repair promoting compounds for treating, reducing and/or preventing stress urinary incontinence and fecal incontinence |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US262115A (en) * | 1882-08-01 | Moeeis pollak | ||
| US5382600A (en) * | 1988-01-22 | 1995-01-17 | Pharmacia Aktiebolag | 3,3-diphenylpropylamines and pharmaceutical compositions thereof |
| SE9203318D0 (sv) * | 1992-11-06 | 1992-11-06 | Kabi Pharmacia Ab | Novel 3,3-diphenylpropylamines, their use and preparation |
| US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
| WO1998003067A1 (en) * | 1996-07-19 | 1998-01-29 | Gunnar Aberg | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| SE9701144D0 (sv) * | 1997-03-27 | 1997-03-27 | Pharmacia & Upjohn Ab | Novel compounds, their use and preparation |
| DE69942928D1 (de) * | 1998-08-27 | 2010-12-23 | Pfizer Health Ab | Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung |
| US6583129B1 (en) * | 1999-06-11 | 2003-06-24 | Watson Pharmaceuticals, Inc. | Administration of non-oral androgenic steroids to women |
| IL157009A0 (en) * | 2001-03-28 | 2004-02-08 | Pfizer | N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
-
2002
- 2002-11-07 EP EP02783937A patent/EP1441707A1/en not_active Withdrawn
- 2002-11-07 CA CA002466336A patent/CA2466336A1/en not_active Abandoned
- 2002-11-07 JP JP2003541815A patent/JP2005512995A/ja not_active Withdrawn
- 2002-11-07 US US10/289,903 patent/US20030118633A1/en not_active Abandoned
- 2002-11-07 MX MXPA04003866A patent/MXPA04003866A/es not_active Application Discontinuation
- 2002-11-07 WO PCT/SE2002/002041 patent/WO2003039524A1/en not_active Ceased
- 2002-11-12 US US10/292,742 patent/US20030130244A1/en not_active Abandoned
- 2002-11-12 CA CA002464707A patent/CA2464707A1/en not_active Abandoned
- 2002-11-12 MX MXPA04004364A patent/MXPA04004364A/es unknown
- 2002-11-12 EP EP02789581A patent/EP1443939A1/en not_active Withdrawn
- 2002-11-12 WO PCT/US2002/036167 patent/WO2003039553A1/en not_active Ceased
- 2002-11-12 JP JP2003541844A patent/JP2005514345A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005512995A5 (https=) | ||
| ES2343595T3 (es) | Comprimido multicapa que se disgrega por via oral. | |
| ES2758831T3 (es) | Nuevas y potentes formas de dosificación de tapentadol | |
| JP5973411B2 (ja) | 医薬組成物 | |
| RU2404750C2 (ru) | Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту | |
| CA2601289A1 (en) | Once-a-day oxycodone formulations | |
| ES2199982T3 (es) | Tableta recubierta de paracetamol y domperidona. | |
| JP2005537268A5 (https=) | ||
| BRPI0714514A2 (pt) | grÂnulo e comprimido para desintegraÇço oral compreendendo oxicodona | |
| IE50984B1 (en) | An orally administered drug form comprising a polar bioactive agent and an adjuvant | |
| JP5137286B2 (ja) | フェンタニル含有口腔粘膜貼付剤 | |
| JP2005508372A (ja) | 薬剤組成物 | |
| JP2009525343A5 (https=) | ||
| JP2002524534A (ja) | 非合法使用に適さない交感神経刺激性アミン塩を含んでなる組成物 | |
| JP2008543936A5 (https=) | ||
| CA2503361A1 (en) | Controlled-release compositions | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| JP2023506545A (ja) | アゴメラチンを含有する経粘膜治療システム | |
| ES2744495T3 (es) | Preparación farmacéutica sólida | |
| EP1786467A1 (en) | Method of enhancing absorptions of transmucosal administration formulations | |
| WO2002034267A8 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
| SK12172000A3 (sk) | Farmaceutické kombinácie obsahujúce tramadol | |
| JP2009517411A5 (https=) | ||
| JP2011516544A5 (https=) | ||
| US20100010029A1 (en) | Acute Pain Medications Based on Fast Acting Diclofenac-Opioid Combinations |